Ronald F. Van Vollenhoven
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 407 publications
Advances in the treatment of systemic lupus erythematosus: Biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic.
Journal: Journal of internal medicine
Published: August 05, 2026
Lupus trials and tribulations: are outcome measures the problem?
Journal: EULAR rheumatology open
Published: August 01, 2026
The EULAR Research Center-5 years young and going strong.
Journal: EULAR rheumatology open
Published: June 29, 2026
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis.
Journal: Journal of internal medicine
Published: April 07, 2026
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: Long-term efficacy and safety through 5 years in the SELECT-EARLY study.
Journal: Modern rheumatology
Published: February 12, 2026
Educational Strategies to Prepare Trainees for Clinical Uncertainty.
Journal: The New England journal of medicine
Published: January 28, 2026
Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trials.
Journal: RMD open
Published: December 09, 2025
Efficacy and safety of anifrolumab in patients with systemic lupus erythematosus without prior immunosuppressant use: post hoc analysis of phase 3 TULIP-1 and TULIP-2 trials.
Journal: Lupus science & medicine
Published: November 13, 2025
Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials.
Journal: Annals of the rheumatic diseases
Published: October 28, 2025
Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials.
Journal: Annals of the rheumatic diseases
Published: October 28, 2025
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus.
Journal: The New England journal of medicine
Published: October 15, 2025
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial.
Journal: The Lancet. Rheumatology
Published: October 02, 2025
Last Updated: 09/26/2026